Welcome to MS Updates. On these pages you will find abstracts from a variety of credible sources related to MS information. MS Updates will include Canadian specific research findings or milestones, noteworthy international research findings, responses to external media releases as well as any other information that may influence the way in which individuals manage their MS.
A Canadian flag beside a summary indicates that one or more of the contributing researchers or authors is Canadian.
The MS Society logo beside a summary indicates that the MS Society of Canada has contributed funding to the work described.
December 14, 2012Early Relapses, Onset of Progression, and Late Outcome in MS
Changes in hospitalization rates and length of stay in people with MS
November 27, 2012High levels of vitamin D among pregnant women are associated with reduced risk of developing MS later
November 26, 2012Results of More Than 1,250 Studies Shared at Global MS Research Meeting
November 16, 2012‘Month of birth’ effect in MS
November 15, 2012Vaccinations and MS
November 5, 2012Findings from two Phase III alemtuzumab studies for relapsing-remitting MS
November 2, 2012Resistance training study showed an improvement in mobility and quality of life
October 22, 2012Ginkgo biloba failed to improve cognitive function in people with MS
September 19, 2012Promising results published on phase III trials of oral BG-12 for relapsing-remitting MS
September 17, 2012FDA approves second oral medication for treatment of relapsing forms of MS
September 4, 2012Researchers Continue With Their Progress in the Seven Funded CCSVI Studies in MS
August 24, 2012Gilenya * Product Monograph Update
August 22, 2012Low dose Ampyra does not improve walking speed in MS: results from a post-marketing study in the US
August 7, 2012Preliminary results of a new class of oral drug that targets inflammation in neurodegenerative conditions reported
July 25, 2012UBC Study observes natural improvement in MS-related disability
July 24, 2012Health Canada and Novartis Pharmaceuticals Canada Inc. Revise Gilenya Label
FDA Warning About Risk of Seizures with MS Drug fampridine
Study Identifies Possible Target of Immune Attacks in Some People with MS
July 23, 2012Phase II trial shows promising results for Masitinib for progressive multiple sclerosis
July 17, 2012UBC study investigates the association between interferon beta therapy and disability progression in relapsing-remitting MS
July 3, 2012Study assesses safety and efficacy of BOTOX® for management of tremor
June 25, 2012Cancer risk in MS: Findings from a UBC study
May 24, 2012Health Canada Approves Updates to TYSABRI® (natalizumab) Product Monograph to Include Anti-JC Virus Antibody Status
Small study reports benefit of cannabis on MS spasticity
Latest results about emerging MS therapies, risk factors, disease mechanisms, rehabilitation, CCSVI, and much more presented at AAN Meeting
May 18, 2012US Food and Drug Administration revises recommendations for cardiovascular monitoring and use of Gilenya (fingolimod)
May 10, 2012FDA issues safety communication about CCSVI and MS
April 13, 2012A case of progressive multifocal leukoencephalopathy (PML) has been reported in an individual being treated with fingolimod (Gilenya)
April 12, 2012FAMPYRA now available for prescription in Canada
March 13, 2012Women’s risk for developing clinically isolated syndrome (CIS) was shown to decrease with increased number of pregnancies
February 29, 2012Biogen Idec applies to FDA for approval of oral BG-12 to treat MS
February 28, 2012Gilenya (fingolimod) under Health Canada review
February 27, 2012Health Canada approves Pr FAMPYRA™ (fampridine) for therapy to improve walking
February 17, 2012Health Canada approves Botox® to treat neurogenic bladder
February 6, 2012Study shows hydrotherapy may improve MS related pain
January 27, 2012Research Teams Report on 18 Months of Progress from MS Societies' Initial Studies on CCSVI and MS
January 23, 2012Fingolimod (Gilenya® ) Under Review
January 1, 2012Study Offers Insight on How Epstein-Barr Virus May Play a Role in MS
2011
December 19, 2011New MRI technique discovered by University of Alberta researchers will help track disease progression
December 15, 2011Researchers identified that a gene that causes vitamin D deficiency may also cause MS
December 14, 2011Possible Safety Issue Being Investigated with Novartis Pill Gilenya
Researchers reveal a dual-protective role of the Hedgehog pathway
November 29, 2011MS Society of Canada announces $3.8 million to study progressive forms of multiple sclerosis
November 25, 2011Common Drug Review Recommends Listing Fingolimod (Gilenya™) Under Public Drug Programs MS Society of Canada Collaborates with CIHR in Call for CCSVI Clinical Trial Research Proposals
November 16, 2011Neuroinflammation and Endoplasmic Reticulum Stress are Co-regulated by Crocin to Prevent Demyelination and Neurodegeneration
November 14, 2011MRI parameters identified for prediction of MS diagnosis in children with acute CNS demyelination
November 9, 2011Neurons Susceptible to Neuronal Damage through a Novel Mechanism Mediated by Granzyme B
November 7, 2011Research Team Discovers New Type of Spinal Cord Stem Cell
B Cell-Derived IL-15 Enhances CD8 T Cell Cytotoxicity and is Increased in MS
November 4, 2011Impaired neurosteroid synthesis in multiple sclerosis
October 6, 2011Teriflunomide: Positive Results Reported Following a Phase III Study
Government of Canada Funds National Neurological Study
August 5, 2011Breakthrough in the Search for New Treatments for MS
Poor Bone Health May Start Early in MS
July 20, 2011New Study on Cost Effectiveness of MS Therapies
July 15, 2011Merck Serono will not proceed with FDA approval of oral cladribine
July 14, 2011Research Teams Report First Year’s Progress From MS Societies’ Initial Studies on CCSVI and MS
July 1, 2011The psychosocial and cognitive impact of longstanding benign MS
June 27, 2011Pregnancy outcomes in women with multiple sclerosis
June 10, 2011Increased Risk of Multiple Sclerosis Following Occurrence of Shingles
June 3, 2011Avonex® PenTM Autoinjector Approved by Health Canada
May 11, 2011MS Research Progress Takes Center Stage at American Academy of Neurology’s Annual Meeting
March 10, 2011First Oral Disease-Modifying Therapy Approved in Canada (Gilenya® )
January 31, 2011Research Teams Report Progress from First Six Months of 2-Year Projects Focusing on CCSVI and MS
2010
November 18, 2010Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
November 4, 2010Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon beta
November 2, 2010MS Researchers Share Progress at Annual ECTRIMS Conference
October 27, 2010Abdominal massage for the alleviation of constipation symptoms in people with multiple sclerosis: a randomized controlled feasibility study
A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis
October 21, 2010Dextromethorphan Plus Ultra Low-Dose Quinidine Reduces Pseudobulbar Affect
MS quality of life, depression, and fatigue improve after mindfulness training
October 14, 2010Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue
October 8, 2010Pathophysiology of multiple sclerosis and the place of teriflunomide
September 16, 2010Calnexin Deficiency Leads to Dysmyelination
The natural history of secondary progressive multiple sclerosis
September 9, 2010A method for evaluating treatment switching criteria in multiple sclerosis
Relevance of cognitive deterioration in early relapsing-remitting MS : a 3-year follow-up study
August 27, 2010Emerging effects of comorbidities on multiple sclerosis
Fatigue, sleepiness, and physical activity in patients with multiple sclerosis
August 23, 2010A ChIP-seq-defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution
August 19, 2010Modifiable factors influencing relapses and disability in multiple sclerosis Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical Studies
Recent Papers Highlight Difficulty of Studying Long-Term Impact on Progression of MS Disease-Modifying Therapies
Emerging Therapies in Relapsing-Remitting Multiple Sclerosis
August 10, 2010Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis
Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity
August 5, 2010A Home-Based Walking Program Using Rhythmic Auditory Stimulation Improves Gait Performance in Patients With Multiple Sclerosis: A Pilot Study
The Effect of Microvascular Decompression in Patients With Multiple Sclerosis and Trigeminal Neuralgia
The natural history of secondary progressive multiple sclerosis
July 29, 2010Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group
Executive Functioning in Children and Adolescents with Multiple Sclerosis
Nocebo effects in multiple sclerosis trials: a meta-analysis
Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course
July 22, 2010Impact on activities of daily living using a functional electrical stimulation device to improve dropped foot in people with multiple sclerosis, measured by the Canadian Occupational Performance Measure
Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients
July 20, 2010Two Medical Meetings (ACTRIMS and CMSC) Focus on Research Progress and Issues in MS Clinical Care
July 12, 2010Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
July 6, 2010A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS
Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis
July 1, 2010New perspectives in the natural history of multiple sclerosis
The natural history of multiple sclerosis, a geographically based study: relapses and long-term disability
Increasing use of disease modifying drugs for MS in Canada
June 23, 2010Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial
Cross-sectional study assessing long-term safety of interferon-{beta}-1b for relapsing-remitting MS
June 21, 2010Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance
June 14, 2010MRI only conversion to multiple sclerosis following a clinically isolated syndrome
June 7, 2010What is the risk of permanent disability from a multiple sclerosis relapse?
Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis
June 3, 2010Vitamin D and multiple sclerosis
Progress on Experimental Therapies for MS, CCSVI Forum, and Much More, Reported at the American Academy of Neurology Meeting
June 1, 2010Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis
Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial
May 31, 2010Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS
May 25, 2010Researchers pave way for the first coordinated international approach to MS stem cell research
Psychosocial issue in children and adolescents with multiple sclerosis
May 19, 2010 Crossover trial of gabapentin and memantine as treatment for acquired nystagmus
May 10, 2010Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices Study Suggests that Smoking and Exposure to Epstein-Barr Virus May Interact as Risk Factors for Developing MS
April 26, 2010Disease onset in familial and sporadic primary progressive multiple sclerosis
Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts
April 22, 2010Relationship of cortical atrophy to fatigue in patients with multiple sclerosis
Clinical trial of a formal group fatigue program in multiple sclerosis
April 7, 2010Pediatric focus continues to shed new light on MS
March 23, 2010Five Studies explore relationship between Epstein-Barr Virus and MS
March 17, 2010Early cognitive impairment in multiple sclerosis predicts disability outcome several years later
Ibudilast in relapsing-remitting multiple sclerosis
March 16, 2010Antiviral immune response in patients with multiple sclerosis and healthy siblings
March 4, 2010Results of Phase II "CHOICE" Study Published, Showing that Daclizumab Reduced Disease Activity in Relapsing MS, and Revealing Novel Immune Mechanism
March 3, 2010Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis
MRI of the corpus callosum in multiple sclerosis: association with disability
Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene
March 1, 2010Atorvastatin Combined with Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy
February 16, 2010High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis
February 2, 2010The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
January 29, 2010Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis
January 28, 2010Results Published from Phase 3 Study of Oral Cladribine in Relapsing-Remitting MS
January 27, 2010Positive Results Published on Clinical Trials of Oral FTY720 (Fingolimod) for Relapsing MS - Novartis Applies to FDA and European Regulatory Agency for Approval
January 26, 2010Regional brain atrophy in primary fatigued patients with multiple sclerosis
January 21, 2010No Effect of Parental Age on Risk of Multiple Sclerosis: A Population-Based Study
January 12, 2010Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
January 11, 2010A randomized trial of memantine as treatment for spasticity in multiple sclerosis
January 8, 2010HLA-DRB1 and month of birth in multiple sclerosis
January 4, 2010Callosal lesion predicts future attacks after clinically isolated syndrome
A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
Back to top
2009
December 10, 2009Positive Results Announced in Phase II Study of IV Ocrelizumab in Relapsing-Remitting MS
November 24, 2009Body size and risk of MS in two cohorts of US women
November 21, 2009 Chronic cerebrospinal venous insufficiency (CCSVI) and MS - Overview and FAQ
November 18, 2009Impact of Multiple Sclerosis Relapses on Progression Diminishes with time
November 9, 2009Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial
October 27, 2009Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis
Consideration of the risk of secondary leukemia after mitoxantrone in multiple sclerosis populations is required
October 20, 2009Two reports for Management of Trigeminal Neuralgia in Multiple Sclerosis
PreCISe Study Results – Showing Benefit of Copaxone® in People at High Risk for MS
October 15, 2009Therapeutic Strategies for MS and More Highlighted at ECTRIMS Conference
October 13, 2009Preliminary work suggests that minocycline as add-on therapy may offer improved efficacy of glatiramer acetate in relapsing-remitting multiple sclerosis. Authors suggest further research needed.
September 22, 2009250 mug or 500 mug interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
Asymptomatic reactivation of JC virus in patients treated with natalizumab
September 10, 2009Correlation between disability and transcranial magnetic stimulation abnormalities in patients with multiple sclerosis
September 9, 2009Effect of immigration on multiple sclerosis female to male ratio in Canada: the Canadian Collaborative Study
September 3, 2009Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis
Gestational diabetes and multiple sclerosis
September 2, 2009Care Given to People with MS by Family Members Presents Unique Challenges - Study funded by National MS Society points to need for respite and mental health support for family care givers
August 31, 2009Sponsor Reports Positive Results of Clinical Trial of Zenvia™ for Pseudobulbar Affect (Uncontrollable Laughing and/or Crying)
August 18, 2009Pilot study of a cognitive intervention program for persons with multiple sclerosis.
July 30, 2009The impact of physical activity on fatigue, depression and quality of life in persons with multiple sclerosis
July 29, 2009Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial In Secondary Progressive Multiple Sclerosis
July 28, 2009Study Adds Evidence that Smoking Worsens MS, and Quitting May Help
July 22, 2009"Benign” Course of MS Evaluated with MRI and Other Imaging Methods by European Collaborators
July 6, 2009Parent-of-origin effect in multiple sclerosis. Observations from interracial matings
Age of onset in concordant twins and other relative pairs with multiple sclerosis
Two Studies Report Finding New Genes and Gene Regions that Make People Susceptible to MS
June 29, 2009Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a
June 24, 2009Two Medical Meetings (ACTRIMS and CMSC) Focus on MS Risk Factors and Quality of Life Issues
June 23, 2009Remyelination capacity of the MS brain decreases with disease chronicity
June 17, 2009Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria
June 15, 2009Randomized Clinical Trial of Balance-Based Torso Weighting for Improving Upright Mobility in People with Multiple Sclerosis
June 9, 2009Report of American Academy of Neurology Meeting Seattle April 2009
June 8, 2009Parity and secondary progression in multiple sclerosis
May 26, 2009Update on oral therapies for MS reported at the American Academy of Neurology Meeting
May 19, 2009Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
May 14, 2009The relationship between handedness and risk of multiple sclerosis
May 11, 2009Multiple Sclerosis and Academic Work: Socio-Spatial Strategies Adopted to Maintain Employment
May 4, 2009The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosisrelated neurogenic bladder dysfunction
April 30, 2009Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T
The search for responsive clinical endpoints in primary progressive multiple sclerosis
April 20, 2009Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors
April 14, 2009Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2-year longitudinal study
March 25, 2009Efficacy of treatment of MS with IFN{beta}-1b or glatiramer acetate by monthly brain MRI in the BECOME study
March 18, 2009Studies Reported: Function, Combination Drug Therapy, Cognition, and Causation
March 17, 2009Genetics Studies Yield New Clues to Why People Get MS New Studies Bolster Possible Link Between Epstein-Barr Virus and MS
March 6, 2009Predicting accidental falls in people with multiple sclerosis -- a longitudinal study
March 3, 2009Young Smokers Increase Risk for Multiple Sclerosis
March 3, 2009
February 23, 2009Results of the Avonex Combination Trial (ACT) in relapsing-remittng MS
February 11, 2009Incidence of acquired demyelination of the central nervous system in Canadian children
February 9, 2009Researchers Report Good Results from Small Study of Stem Cell Therapy to “Reboot” Immune System in MS
February 5, 2009Genetic study supports vitamin D deficiency as an environmental factor in MS susceptibility
January 28, 2009Oral Cladribine Reduces MS Relapses in Phase 3 Clinical Trial
January 15, 2009Restless Leg Syndrome in multiple sclerosis:A case-control study
January 8, 2009Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support. Oral FTY720 (Fingolimod) Reduced Relapse Rate More Effectively Than Avonex in Initial Results of One-Year Study in Relapsing-Remitting MS Dr. Brenda Banwell, a well known Canadian pediatric researcher, is an author on 2 papers about the use of MRI in children with MS, published in Neurology.
Back to top
2008
November 17, 2008Researchers find a key player in the maintenance of myelin
November 13, 2008 Researchers demonstrate a potential association between monthly ambient sunlight, infections and relapse rates in Multiple Sclerosis
November 4, 2008 Results Published: Oral Drug BG00012 Reduced MRI Inflammation
in Relapsing-Remitting MS During Phase 2 Trial
November 3, 2008 Alemtuzumab Results Published: Reduced MS Relapses and Accumulation
October 27, 2008 Teams Funded by the National MS Society Report
on Key Enzymes Related to MS Progression and Nervous System Repair
October 16, 2008 Investigators Find No Overall Link Between Hepatitis B Vaccine
and MS
October 2, 2008 World congress on MS takes
place in Montreal
September 10, 2008 Higher levels of 25-hydroxyvitamin D are associated with a lower
incidence of multiple sclerosis only in women
September 3, 2008 New Recommendations from the FDA Concerning
the Monitoring of Cardiac Function in People Taking Mitoxantrone
August 21, 2008 Canadian Collaborative Project on Genetic Susceptibility to
MS provides data to study exploring risk of developing MS for
preterm babies
August 18, 2008 Researchers suggest that latitude and sex ratio trends in the
incidence of multiple sclerosis may be shifting
August 13, 2008 Biogen Idec and Elan Pharmaceuticals
informed drug regulatory authorities about two new confirmed
cases of
PML(progressive
multifocal leukoencephalopathy) in individuals who were taking
Tysabri® (natalizumab) as a monotherapy (not in combination
with other therapies).
August 13, 2008 Smoking is a risk factor for early conversion to clinically definite multiple sclerosis
August 13, 2008 Sleep problems in people with MS are prevalent
July 7, 2008 Effectiveness of Rehabilitation Intervention in
Persons with Multiple Sclerosis: A randomized controlled trial
July 3, 2008 Laquinimod Results Published: Oral Drug Reduces
Disease Activity in Phase 2 Study
June 27, 2008 Molecule Strikes Balance in Immune System and
May Be Key to Autoimmune Attack in MS
June 13, 2008 Serious Infections Experienced by Two People Participating in
Clinical Trials of FTY720 for MS
June 11, 2008 Fampridine-SR Improves Walking Speed in All Types
of MS in Second Phase 3 Study
June 10, 2008 New Study Suggests Immune Genes Help Determine Sites of MS Damage and Symptoms
May 23, 2008 Progress on Experimental Therapies for MS, and
Much More, Reported at the American Academy of Neurology Meeting
May 15, 2008Stem Cell Treatments in China
April 29, 2008 Disappointing Results from Trial of Rituximab
in Primary Progressive MS
April 22, 2008Investigators Explore MS Risk Conferred by Combination of Gene
and Virus
April 21, 2008Norwegian Researchers Confirm Higher Rates of Symptoms of Depression
and Anxiety in People with MS
April 3, 2008 Combined treatment with atorvastatin and minocycline suppresses
severity of EAE
April 2, 2008 Acne medication may delay progress of multiple
sclerosis
March 27, 2008 Compound Protects Nerves from Injury in National MS Society-funded
Study of Mice with Progressive MS
February 28, 2008 "Street" Marijuana Harmful
to Cognitive Function in MS Patients
February 19, 2008 Phase ll trial suggests Rituximab may reduce MS Disease Activity
January 16, 2008 MS Therapy may help delay conversion from CIS to clinically
definite MS
January 11, 2008Two year pilot study suggests that
combination therapy with interferon Beta-1b and azathioprine
may help slow the course of SPMS
January 9, 2008Large-scale analysis from Nova
Scotia suggests that disease-modifying drugs for MS are effective
in reducing
disability
progression
in people whose MS started with relapses
Back to top
2007
November 6, 2007 Researchers Report Findings on Antibody That Stimulates Myelin
Repair
October 31, 2007 Research Progress Reported at International
ECTRIMS Meeting
October 31, 2007 Eye Scan May Help Diagnose, Treat MS
October 25, 2007Acne medication may delay
progress of multiple sclerosis
September 19, 2007Parental smoking at home and the risk of childhood-onset multiple sclerosis in children
August 17, 2007 Experimental MS vaccine shows beneficial changes
in immune system
August 14, 2007 Interferon injection may delay disability accumulation
August 8, 2007 Study Finds Early Sun Exposure Associated with Reduced Risk of
MS
July 31, 2007 International Collaborators Identify New Genetic
Risk Factors for MS
July 25, 2007A timing-of-birth effect on risk for multiple sclerosis
July 23, 2007 Immune system variations may underlie differences in MS between African Americans and Caucasians
July 18, 2007ACTRIMS and CMSC meetings focus on emerging MS therapies and quality of life issues
June 2007MS Disease-Modifying Therapies in Canada only
May 24, 2007 Easier access to multiple sclerosis treatments will reduce overall healthcare costs: MS Society
May 8, 2007The Canadian endMS Research Conference - Banff, Alberta - December 10 to 13, 2007
May 2007Progress on Experimental Therapies for MS, and Much More, Reported at the American Academy of Neurology Meeting - April 28 to May 4, 2007
April 13, 2007Researchers Stop MS-like disease in Mice by Targeting a Blood Protein
April 13, 2007 Frequently Asked Questions on Tysabri
February 22, 2007Clinical trial of oral therapy in relapsing remitting MS
February 22, 2007Pregnancy hormone key to repairing nerve cell damage
February 12, 2007Benign MS
January 29, 2007Clinical trial results
for oral therapy fingolimod show reduction of disease activity:
Larger study now recruiting participants
January 24, 2007Clinical trial of MBP8298 expands to United States
January 4, 2007Later onset of MS does
not necessarily lead to worse outcome: University of British
Columbia study
Back to top
Back to top
Charitable registration
Multiple Sclerosis Society of Canada
Toll free to reach
the nearest regional office: 1 800 268-7582
E-mail: info@mssociety.ca (Please provide your town and
province in your e-mail)
© Multiple Sclerosis Society of Canada
Multiple Sclerosis Living with MS Research Treatments Donate Now Get Involved Special Events
Home
About Us Advocacy Media
Contact Us Site
Map Privacy
Français
